Permeability and patency of retinal blood vessels in experimental diabetes
- PMID: 852945
Permeability and patency of retinal blood vessels in experimental diabetes
Abstract
Increased permeability of retinal blood vessels in human diabetic retinopathy is well known clinically. Its morphologic equivalent is unknown. In dogs with 5 years of poorly controlled alloxan diabetes and nonproliferative diabetic retinopathy comparable to that of man, permeability and patency of retinal blood vessels were tested with the protein tracer horseradish peroxidase and evaluated by electron microscopy. A breakdown of the blood-retinal barrier was found associated with extensive tracer leakage around retinal blood vessels. Tracer had seemingly permeated endothial junctions, and was not transported through the endothelial cytoplasm. Blood vessels which had lost their endothelial cells and were partially occluded by glial cells retained some patency to tracer. These findings suggest the following. (1) Endothelial tight junctions are not a static cell specialization but one that can open due to chronic metabolic or osmotic factors prevailing in diabetes. Opened tight junctions may account for plasma leakage seen clinically in human diabetic retinopathy. (2) In the absence of endothelial cells perfusion does not necessarily end abruptly. The tracer method and electron microscopy may show details of vascular obstruction that are not readily demonstrated clinically.
Similar articles
-
Pathologic studies of the blood--retinal barrier in the spontaneously diabetic BB rat.Invest Ophthalmol Vis Sci. 1984 Mar;25(3):302-11. Invest Ophthalmol Vis Sci. 1984. PMID: 6698748
-
Experimental macular edema after lens extraction.Invest Ophthalmol Vis Sci. 1977 May;16(5):381-92. Invest Ophthalmol Vis Sci. 1977. PMID: 404267
-
Proteolytic degradation of VE-cadherin alters the blood-retinal barrier in diabetes.Diabetes. 2007 Sep;56(9):2380-7. doi: 10.2337/db06-1694. Epub 2007 May 29. Diabetes. 2007. PMID: 17536065
-
Molecular mechanisms of vascular permeability in diabetic retinopathy.Semin Ophthalmol. 1999 Dec;14(4):240-8. doi: 10.3109/08820539909069543. Semin Ophthalmol. 1999. PMID: 10758225 Review.
-
Involvement of cell-cell interactions in the pathogenesis of diabetic retinopathy.Diabetes Metab. 1997 Feb;23(1):30-42. Diabetes Metab. 1997. PMID: 9059764 Review.
Cited by
-
Microalbuminuria and nephropathy in insulin dependent diabetes mellitus.Arch Dis Child. 1995 Jul;73(1):4-7. doi: 10.1136/adc.73.1.4. Arch Dis Child. 1995. PMID: 7639548 Free PMC article. No abstract available.
-
Increased growth hormone response to dopamine infusion in insulin-dependent diabetic subjects: indication of possible blood-brain barrier abnormality.J Clin Invest. 1980 Jan;65(1):146-53. doi: 10.1172/JCI109644. J Clin Invest. 1980. PMID: 7350194 Free PMC article.
-
Cellular signaling and potential new treatment targets in diabetic retinopathy.Exp Diabetes Res. 2007;2007:31867. doi: 10.1155/2007/31867. Exp Diabetes Res. 2007. PMID: 18288248 Free PMC article. Review.
-
Developments in the pathology of diabetic retinopathy: a review.J R Soc Med. 1981 Jun;74(6):427-31. doi: 10.1177/014107688107400607. J R Soc Med. 1981. PMID: 7019436 Free PMC article. Review. No abstract available.
-
Binding and transcytosis of glycoalbumin by the microvascular endothelium of the murine myocardium: evidence that glycoalbumin behaves as a bifunctional ligand.J Cell Biol. 1988 Nov;107(5):1729-38. doi: 10.1083/jcb.107.5.1729. J Cell Biol. 1988. PMID: 3182935 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources